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Summary
We tested the hypothesis that susceptibility to relapsing-
progressive (RP) (but not to relapsing-remitting [RR])
multiple sclerosis (MS) is associated with a gene linked
to the TcR b-chain variable region delimited by the Vb8-
BamHI and Vb11-BamHI RFLP alleles in DRw15 MS
patients, using a contingency-table test of patient data
and affected family–based controls. Control alleles and
haplotypes were composed of parental marker alleles
and haplotypes not transmitted to the affected child, in
90 simplex and 31 multiplex families from British Co-
lumbia. A total of 6,164 alleles at 11 loci were segregated
through families of probands with RP MS or RR MS.
The Vb8–Vb11 subhaplotype frequencies in the
DRw15 RP MS (but not RR MS) patients differed from
control frequencies, because of an increase of the 2-1
subhaplotype ( ). Vb8-BamHI and Vb11-BamHIP  .02
allele frequencies ( and .009, respectively) in theP  .05
DRw15 RP MS (but not RR MS) patients differed from
control frequencies. The Vb1–Vb8 subhaplotype fre-
quencies in the DRw15 RP MS (but not RR MS) pa-
tients differed from control frequencies ( ), withP  .03
a significantly increased frequency of the 1-1 subhap-
lotype ( ; ) in RP MS versus RR MSP  .01 RR  7.1
patients. Susceptibility to RP MS is associated both with
a recessive inheritance of a gene linked to the 3′ (Vb11)
end of the 2-1 subhaplotype defined by the Vb8-BamHI
and Vb11-BamHI alleles in DRw15 patients and with
a gene, located on the 1-1 subhaplotype, defined by the
Vb1-TaqI and Vb8-MspI alleles of the TcR b-chain com-
plex in DRw15 patients.
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Introduction
Liability (Falconer 1989) to develop multiple sclerosis
(MS; MIM 126200 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?126200]) is partly deter-
mined by an underlying genetic susceptibility due to the
inheritance of at least two unlinked gene complexes
(Ebers at al. 1986, 1996; Risch 1987; Sadovnick et al.
1993; Ebers 1994; Haines et al. 1996; Sawcer et al.
1996). There may be multiplicative interactions involved
between these loci (Beall et al. 1989, 1993; Kellar-Wood
et al. 1995; Epplen et al. 1997). The liability is also
determined by modulation of the expression of these
genes through the immune system and by exposure to
environmental factors. Major candidate-gene complexes
include the HLA locus (specifically the DR, DQ, and DP
loci; reviewed in Tiwari and Terasaki 1985; Olerup and
Hillert 1991; Haegert and Marrosu 1994; Hillert 1994),
which encodes self-molecules, which present processed
peptides to the protein products on T cells encoded by
two other candidate gene complexes, the TcR a- and b-
chain loci (reviewed in Beall et al. 1989, 1993; Haegert
and Marrosu 1994; Hauser 1995).
The TcR is a heterodimer comprising a and b chains,
each of which is divided into variable (V) and constant
(C) regions (Rowen et al. 1996). We originally showed
association of the TcR b-chain genes with susceptibility
to MS in chronic progressive (CP), primarily DR2
(DRw15), MS patients (Beall et al. 1987a, 1989). A
nonparametric linkage study of 40 affected sib pairs
(ASPs) showed linkage between this locus and suscep-
tibility (Seboun et al. 1989). The twomajor animal mod-
els of the disease that have been studied most
extensively—experimental allergic encephalomyelitis
(EAE) and Theiler’s murine encephalomyelitis virus
(TMEV)–induced demyelinating disease—also provide
strong evidence that the TcR b-chain locus is a major
susceptibility gene if coinherited with another suscepti-
bility locus, H-2 (equivalent to the HLA locus of the
human) (Melvold et al. 1987; Rodriguez et al. 1992,
1994; Goverman et al. 1993).
There have been a number of investigations of the
TcR b-chain locus and susceptibility to MS. Case-con-
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trol studies have yielded either positive (Beall et al. 1989,
1993; Charmley et al. 1991; Martinez-Naves et al. 1993;
Epplen et al. 1997) or negative (Fugger et al. 1990; Hil-
lert et al. 1991; Vandevyver et al. 1994; Wei et al. 1995;
Droogan et al. 1996) results. Linkage studies using non-
parametric methods also have yielded either positive (Se-
boun et al. 1989; Wood et al. 1995; Haines et al. 1996)
or negative (Lynch et al. 1991; Ebers et al. 1996; Sawcer
et al. 1996) results.
The classic way to determine whether genes confer
susceptibility to MS is to determine whether they are
linked or associated with the disease (reviewed in Thom-
son 1991). Previous linkage studies that used parametric
methods may be inappropriate in the study of diseases
with multigenic inheritance (Thomson 1991). Previous
association studies that used population-based controls
have been plagued with possible experimental bias due
to the mismatching of controls and patients with regard
to ethnic diversity (Ebers and Sadovnick 1994). These
problems can be lessened by the use of affected fam-
ily–based controls (AFBACs) (Falk and Rubinstein
1987; Thomson 1988, 1991, 1995; Thomson et al.
1989; Beall et al. 1993, 1995, 1996; Beall and Hockertz
1993; Schaid and Sommer 1993; Spielman et al. 1993;
Ebers 1994; Ebers and Sadovnick 1994; Khoury 1994;
Suarez and Hampe 1994; Hockertz et al. 1996; Risch
and Merikangas 1997; S. S. Beall, unpublished data).
In addition to the aforementioned methodological
problem, there is also a problem introduced by the very
nature of MS. Approximately 10% of cases will undergo
a “benign” course—that is, either start as relapsing re-
mitting (RR) and be virtually normal after 22 years or
allow the affected individual to walk, with aids, 35 years
after onset (Weinshenker et al. 1989). Approximately
15% of cases will be chronically progressive (CP); 85%
of cases start as RR, and then more than half of this
latter group enters a relapsing-progressive (RP) phase
after 10 years of disease (Weinshenker et al. 1989). The
population of MS patients may thus actually constitute
a continuum that ranges fromMS patients whose disease
remains relatively benign (i.e., RR) as they age to MS
patients whose disease progresses quickly. The particular
point that each patient occupies on the continuum will
be determined by the genes inherited and by the envi-
ronment encountered. Therefore, the disparity of results
reported in the past may also be explained by the fact
that different groups of patients with different severities
of the disease have been studied. We (Beall et al. 1987a,
1989, 1993; Charmley et al. 1991; Beall and Hockertz
1993; Hockertz et al. 1996) have been especially inter-
ested in the RP and CP patients, since they have the
worst prognosis and should be given priority of under-
standing and treatment.
In the past we have also focused on DRw15 patients,
since (1) these patients constitute the majority, and (2)
it was in these patients that we reported the initial as-
sociation between susceptibility to the progressive form
of MS and the TcR b-chain locus, a hypothesis that has
received recent support from a nonparametric linkage
study (Kellar-Wood et al. 1995; Wood et al. 1995) and
a very large case-control study (Epplen et al. 1997). It
is not unexpected therefore that previous studies that
did not stratify patients as to HLA class II type would
show results different from our own previously pub-
lished results (Beall et al. 1987a, 1989, 1993; Charmley
et al. 1991).
The results of our previous studies (Beall et al. 1987a,
1989, 1993) support the following hypothesis. In the
TcR b-chain V region, a gene(s) may exist that predis-
poses to progression of disease if this gene is coinherited
with a DRB1*1501 (DR2 or DRw15)–DQB1*0602
(DQ1 or DQw6) HLA class II haplotype. This gene will
be at the 3′ (Vb11) end of a subhaplotype delimited by
the Vb8 and Vb11 DNA polymorphisms. To avoid pre-
vious biases (see above), the hypothesis should be tested
by use of AFBACs. The present study was designed to
test this hypothesis.
Subjects and Methods
Subjects
As of 1995, 3,683 patients had been registered in the
MS clinic in Vancouver, which is believed to be the larg-
est MS clinic in the world (Redekop 1995). It is also
unique in that (1) clinical data for all probands are stored
in a computerized database (COSTAR [computer-stored
ambulatory record) (Paty et al. 1994), (2) the diagnosis
of MS is made by neurologists specialized in the diag-
nosis of MS, (3) clinical data are updated at each patient
visit and are entered into COSTAR, and (4) pedigrees
are updated annually by a clinical geneticist (Sadovnick
1994). Because this is a population-based clinic, it is free
from ascertainment bias that may occur in clinics that
are part of tertiary-care referral centers. After the pro-
posed study was approved by the institution’s ethics
committee, blood was obtained, in coded fashion, from
simplex families (those in which one nuclear-family
member has MS) and multiplex families (those in which
more than one nuclear-family member is affected with
MS).
Blood was collected from 90 simplex families (which
can be utilized for calculation of risk and control allele,
genotype, and haplotype frequencies) and from 31 mul-
tiplex families comprising ASP, parent-child, and par-
ent–child–sib-pair families (which also can be used as a
source of control alleles, genotypes, and haplotypes). Of
the simplex families, 80 contained both parents, and 10
had one parent and an unaffected sib available for study.
Alleles were typed in the families in a blinded fashion
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and, after alleles and haplotypes were determined, the
code was broken as to simplex or multiplex status. In
addition, at that time, COSTAR (Paty et al. 1994) was
accessed to see which of the children was the affected
proband and which type of MS (i.e., RR or RP) the
proband had. Because this is a family-based association
test, the control genotype was defined as the two alleles
not passed to the proband (Lander and Schork 1994).
In this study, 68% of the probands of the simplex fam-
ilies were RR MS, and 32% of the probands were RP
MS. All probands fulfilled criteria for definite diagnosis
of MS (Poser et al. 1983).
DNA Preparation and Cataloguing
Genomic DNA was prepared from peripheral blood
lymphocytes from venous blood from the proband and
first-degree relatives, as described elsewhere (Beall et al.
1987b). Each subject was assigned a unique eight-digit
ID number, which, together with experimental data, was
entered into a computer heuristic, CHIAARRA (com-
puterized heuristic of Internet accessible alleles for re-
lational retrieval and analysis), that we have designed
(Beall et al. 1996; S. S. Beall, M.K. Hockertz, D. Studney,
and D.W. Paty, unpublished data). This heuristic permits
automatic calculation of experimental variables for mo-
lecular genotyping and semiautomated entry and anal-
ysis of segregated allele data. The heuristic also effec-
tively links the phenotypic (clinical) data, genetic
(clinical) data, and genotypic (molecular genotype) data
within a system of distributed relational databases and
database-analysis programs, which can be viewed uni-
versally by way of a PC with access to the Internet (Beall
et al. 1996; S. S. Beall, M.K. Hockertz, D. Studney, and
D.W. Paty, unpublished data).
Probes
Plasmids containing cDNA inserts for DR b and DQ
b HLA class II exons and for DQ a class II exons have
been described elsewhere (Beall et al. 1995). In addition,
we have previously described plasmids containing cDNA
inserts for TcR Vb7, TcR Vb1, TcRVb8, and TcRVb11
exons (Beall et al. 1989, 1993). cDNA isolation from
the plasmids was as described elsewhere (Beall et al.
1987b), and radioisotope labeling from gel-purified in-
serts of these cDNAs was also as described elsewhere
(Beall et al. 1989, 1993).
Southern Blot Analysis
DNA samples from patients and from their first-de-
gree relatives were digested with the restriction enzymes
BamHI, TaqI, and MspI. Southern blots were prepared
as described elsewhere (Beall et al. 1989). Hybridization
in a rotisserie oven (Hybaid) was performed under con-
ditions described elsewhere (Beall et al. 1993). After a
washing, blots were stripped and hybridized sequentially
with the HLA DR b, TcR Vb7, TcR Vb1, TcR Vb8,
and TcR Vb11 probes. To detect the HLA DR and TcR
polymorphisms, filters were washed and autoradiogra-
phy was performed as described elsewhere (Cox et al.
1988; Beall et al. 1989, 1993, 1995).
PCR-Based RFLP Analysis
The TcR Vb6.1, TcR Vb6.3, TcR Vb6.7, and TcR
Vb6.10 dinucleotide repeat polymorphisms were deter-
mined as described elsewhere (Charmley and Concan-
non 1993). To detect the Vb8-BamHI polymorphism
(Concannon et al. 1987), PCR primers AP6′ (5′-CCT
TGC CAC ATA ATT TAA CAC-3′) and 8154 (5′-TGC
CAA CAA AAG AGA AGG GC-3′) were developed
(GenBank accession numbers L36092 and L36190 [http:
//www.ncbi.nlm.gov/]), which allowed detection of this
polymorphism by use of PCR-based methods. To detect
the Cb-BglII polymorphism (Robinson and Kindt 1985),
PCR primers SB20 (5′-GGA ATG GAT AAG ATG ACT
TC-3′) and SB21 (5′-AAT CCT CTT TGA TGG TTC
TAC C-3′) were developed, which allowed detection of
this polymorphism. To detect the Cb KpnI polymor-
phism (Perl et al. 1989), PCR primers SB22 (5′-GGC
TCA ATG TCC TTA CAA AGC-3′) and SB23 (5′-ATG
TTC CAT CCC CTG CCC CCA TCA TC-3′) were de-
veloped. Genomic DNA was then amplified, with the
AP6′ and 8154 primers, for 35 cycles of 1 min at 92C,
1 min at 55C, and 1½ min at 72C. To detect the Cb-
BglII and KpnI polymorphisms, genomic DNA was am-
plified with the specified primers for 35 cycles of 1 min
at 92C, 1 min at 60C, and 1 min at 72C, in a total
volume of 20 ml. All reactions were performed in a Perkin
Elmer Cetus model 480 DNA thermocycler by standard
procedures. The “hot start” technique was used for the
SB22 and SB23 primers, to avoid primer-dimer forma-
tion. All PCRs are now performed using of Ultra Therm
Taq polymerase (0.05 units/reaction). After genomic
DNA amplification, 2–4 units of requisite restriction en-
zyme was added to 5 ml of each PCR, and the product
was electrophoresed through a 2% agarose gel.
Segregation of Alleles and Analysis of Data
Autoradiographs, sequencing gels, and agarose-gel
patterns were analyzed, and alleles were segregated
through the simplex and multiplex pedigrees. All alleles
followed Mendelian segregation. For determination of
risk genotypes and alleles, data from simplex families
were utilized. Control genotypes were constructed from
alleles not passed either to the proband (Lander and
Schork 1994), in the case of simplex families, or to af-
fected sibs from unaffected parents, in the case of mul-
tiplex families. For families with only one living parent,
the alleles of the deceased parent could be reconstructed
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Figure 1 Assignment of at-risk and control alleles and subhap-
lotypes, by use of AFBACs. Dinucleotide repeat polymorphisms were
used to help establish phase but were not utilized in the genotype or
haplotype analysis. In this illustrative example of one of the MS sim-
plex families from the University of British Columbia, phase has been
established by use of seven markers (see legend beside the pedigree
and correlate with the previously published map of the TcR b-chain
locus [Beall et al. 1993]). Proband 7074-03 inherits the maternal hap-
lotype 3-2-1-2-1-1-1 (b) and the paternal haplotype 2-2-1-2-1-1-1 (c).
Risk alleles for Vb11 are 1,1, and control alleles are those carried on
the a and d control haplotypes (chromosomes not passed to the pro-
band), which are equivalent to 2,1. The proband inherits the disease
subhaplotypes 2-1 and 2-1 delimited by the Vb8-BamHI and Vb11-
BamHI markers (further described by Beall et al. [1987a, 1989, 1993]).
In this manner, 6,164 alleles were scored through the families, to obtain
the data in tables 1–3.
on the basis of the unaffected sib. In the rare instances
when this was not possible, the genotype of the unaf-
fected sib was used as the control genotype (Field et al.
1991). After data were tabulated, genotype and allele
frequencies, as well as Hardy-Weinberg equilibrium
(HWE) calculations, were determined by use of a cus-
tomized analysis program built within CHIAARRA
(Beall et al. 1996; S. S. Beall, M.K. Hockertz, D. Studney,
and D.W. Paty, unpublished data).
Statistical Analysis
The x2 contingency-table test for heterogeneity was
used for comparisons of allele, genotype, and haplotype
frequencies in patients versus controls, by use of stan-
dard methods (Crow 1986). The smallest classes were
combined, so that expected numbers were not less than
five in the x2 test, although this may be overly conser-
vative (Cochran 1954). We used one-tailed tests and did
not apply Bonferroni corrections (Ingelfinger et al. 1983)
to obtain probability tests of previous hypotheses; we
used two-tailed tests and applied Bonferroni corrections
to obtain probability tests of new hypotheses.
Results
Determination of Genotype, Allele, and Subhaplotype
Frequencies in the HLA Class II and TcR b-Chain Loci
As an initial step, the 90 simplex families were typed
at the HLA class II locus, as described elsewhere (Bidwell
et al. 1987; Cox et al. 1988; Horne and Keown 1993;
Beall et al. 1995), and will form part of the data set of
a separate report. A total of 52% of the probands of
the simplex families in this study were DRw15.
Genotypes were determined at nine TcR V-region loci
and at two C-region loci, in 90 simplex families and 31
multiplex families (for alleles and subhaplotypes used in
the analysis, see fig. 1). A total of 6,164 alleles were
manually segregated through the families in a coded
fashion (HLA status, individuals affected with MS, and
RR/RP status were unknown). After segregation of al-
leles, they were entered into CHIAARRA (Beall et al.
1996; S. S. Beall, M.K. Hockertz, D. Studney, and D.W.
Paty, unpublished data). COSTAR (Paty et al. 1994) was
then accessed, and the code was broken as to affected
status. Genotype frequencies and allele frequencies were
then determined (tables 1 and 2). All genotypes were in
HWE (table 1). Subhaplotypes (Beall et al. 1993) were
determined at each portion of the TcR b-chain locus
(fig. 1). Subhaplotype frequencies were calculated in a
way analogous to that described above for genotype and
allele frequencies and are presented in table 3.
Susceptibility to RP MS (but Not to RR MS),
in DRw15 Patients
As the initial step in this study, we tested the hypoth-
esis that susceptibility to DRw15 RP MS is associated
with a gene linked to the region delimited by the Vb8-
BamHI and Vb11-BamHI loci (Beall et al. 1987a, 1989,
1993). Frequencies of the subhalotypes delimited by the
Vb8-BamHI and Vb11-BamHI loci (but not in the
regions flanking this region) were significantly different
from control frequencies, in the DRw15RPMS portion
of the data set ( ; ) (table 4). The major2x  6.19 P  .022
contributors to this difference were the increased rep-
resentation, in the DRw15 RP MS patients, of the 2-1
subhaplotypes (67% vs. 42%) ( ; ;2x  6.17 P  .0061
corrected ; ), as well as a decreasedP  .018 RR  2.74
representation of the 1-2 subhaplotype (30% vs. 51%)
( ; ; corrected ; ). This2x  4.65 P  .02 P  .06 RR  .411
effect was not seen in DRw15 RR MS patients ( 2x 2
; ). Subhaplotype frequencies in DRw15 RP.40 P  .82
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Table 1
Genotype Frequencies Determined on the Basis of Vb and Cb Alleles in Caucasian MS Simplex and Multiplex Families from
British Columbia
TcR b
GENOTYPEa
NO. (FREQUENCY) OF WITH GENOTYPE
DRw15
and
DRw15
At Risk
Control
DRw15 DRw15
All RR MS RP MS All RR MS RP MS
Vb7-BamHI:
1,1 26 (.29) 14 (.30) 12 (.39) 2 (.13) 12 (.28) 6 (.20) 6 (.46) 21 (.23)
1,2 36 (.40) 17 (.36) 12 (.39) 5 (.31) 19 (.44) 15 (.50) 4 (.31) 37 (.41)
1,3 12 (.13) 7 (.15) 3 (.10) 4 (.25) 5 (.12) 4 (.13) 1 (.08) 17 (.19)
2,2 8 (.09) 4 (.09) 2 (.06) 2 (.13) 4 (.09) 3 (.10) 1 (.08) 7 (.08)
2,3 8 (.09) 5 (.11) 2 (.06) 3 (.19) 3 (.07) 2 (.07) 1 (.08) 8 (.09)
3,3 0 (.00) 0 (.00) 0 (.00) 0 (.00) 0 (.00) 0 (.00) 0 (.00) 0 (.00)
Total 90 47 31 16 43 30 13 90
HWEb  2.182x3  1.29
2x3  .61
2x3  1.48
2x3  1.19
2x3  2.37
2x3  .66
2x3  5.29
2x3
Vb1-TaqI:
1,1 3 (.03) 2 (.04) 1 (.03) 1 (.06) 1 (.02) 0 (.00) 1 (.08) 4 (.04)
1,2 18 (.20) 10 (.21) 3 (.10) 7 (.44) 8 (.19) 4 (.13) 4 (.31) 24 (.27)
2,2 69 (.77) 35 (.75) 27 (.87) 8 (.50) 34 (.79) 26 (.87) 8 (.62) 62 (.69)
Total 90 47 31 16 43 30 13 90
HWEb  1.632x1  1.21
2x1  3.74
2x1  .11
2x1  .39
2x1  .15
2x1  .23
2x1  .70
2x1
Vb8-MspI:
1,1 42 (.47) 23 (.49) 13 (.42) 10 (.63) 19 (.45) 16 (.55) 3 (.23) 38 (.44)
1,2 37 (.42) 21 (.45) 16 (.52) 5 (.31) 16 (.38) 8 (.28) 8 (.62) 40 (.46)
2,2 10 (.11) 3 (.06) 2 (.06) 1 (.06) 7 (.17) 5 (.17) 2 (.15) 9 (.10)
Total 89 47 31 16 42 29 13 87
HWEb  .182x1  .39
2x1  2.64
2x1  .12
2x1  1.22
2x1  3.67
2x1  .74
2x1  .10
2x1
Vb8-BamHI:
1,1 23 (.26) 12 (.26) 10 (.32) 2 (.13) 11 (.26) 7 (.23) 4 (.31) 23 (.26)
1,2 40 (.40) 18 (.38) 11 (.35) 7 (.44) 22 (.51) 15 (.50) 7 (.54) 42 (.47)
2,2 27 (.30) 17 (.36) 10 (.32) 7 (.44) 10 (.23) 8 (.27) 2 (.15) 25 (.28)
Total 90 47 31 16 43 30 13 90
HWEb  1.082x1  2.39
2x1  2.61
2x1  .15
2x1  .02
2x1  .00
2x1  .14
2x1  .40
2x1
Vb11-BamHI:
1,1 25 (.28) 16 (.34) 8 (.26) 8 (.50) 9 (.21) 7 (.23) 2 (.15) 21 (.24)
1,2 41 (.46) 19 (.40) 13 (.42) 6 (.38) 22 (.51) 17 (.57) 5 (.38) 42 (.47)
2,2 24 (.27) 12 (.26) 10 (.32) 2 (.12) 12 (.28) 6 (.20) 6 (.46) 26 (.29)
Total 90 47 31 16 43 30 13 89
HWEb  .712x1  1.62
2x1  .77
2x1  .26
2x1  .03
2x1  .54
2x1  .29
2x1  .25
2x1
Cb BglII:
1,1 22 (.24) 11 (.23) 6 (.19) 5 (.31) 11 (.26) 9 (.30) 2 (.15) 30 (.34)
1,2 44 (.49) 22 (.47) 16 (.52) 6 (.38) 22 (.51) 15 (.50) 7 (.54) 38 (.43)
2,2 24 (.27) 14 (.30) 9 (.29) 5 (.31) 10 (.23) 6 (.20) 4 (.31) 20 (.23)
Total 90 47 31 16 43 30 13 88
HWEb  .042x1  .17
2x1  .06
2x1  1.00
2x1  .02
2x1  .003
2x1  .14
2x1  1.38
2x1
Cb KpnI:
1,1 10 (.16) 4 (.13) 3 (.17) 1 (.08) 6 (.20) 3 (.17) 3 (.25) 10 (.17)
1,2 23 (.38) 14 (.45) 7 (.39) 7 (.54) 9 (.30) 5 (.28) 4 (.33) 31 (.53)
2,2 28 (.46) 13 (.42) 8 (.44) 5 (.39) 15 (.50) 10 (.56) 5 (.42) 18 (.30)
Total 61 31 18 13 30 18 12 59
HWEb  1.862x1  .01
2x1  .45
2x1  .46
2x1  3.48
2x1  2.12
2x1  1.18
2x1  .30
2x1
a Allele designations are as in figure 1.
b x2Test statistic for HWE.
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Table 2
Allele Frequencies Determined on the Basis of Vb and Cb Alleles in Caucasian MS Simplex and Multiplex
Families from British Columbia
TcR b
ALLELEa
NO. (FREQUENCY) OF ALLELES
DRw15
and
DRw15
At Risk
Control
DRw15 DRw15
All RR MS RP MS All RR MS RP MS
Vb7-BamHI:
1 100 (.56) 52 (.55) 39 (.63) 13 (.41) 48 (.56) 31 (.52) 17 (.65) 104 (.53)
2 60 (.33) 30 (.32) 18 (.29) 12 (.38) 30 (.35) 23 (.38) 7 (.27) 62 (.32)
3 20 (.11) 12 (.13) 5 (.08) 7 (.22) 8 (.09) 6 (.10) 2 (.08) 29 (.15)
Total 180 94 62 32 86 60 26 195
Vb1-TaqI:
1 24 (.13) 14 (.15) 5 (.08) 9 (.28) 10 (.12) 4 (.07) 6 (.23) 33 (.17)
2 156 (.87) 80 (.85) 57 (.92) 23 (.72) 76 (.88) 56 (.93) 20 (.77) 160 (.83)
Total 180 94 62 32 86 60 26 193
Vb8-MspI:
1 121 (.68) 67 (.71) 42 (.68) 25 (.78) 54 (.64) 40 (.69) 14 (.54) 123 (.66)
2 57 (.32) 27 (.29) 20 (.32) 7 (.22) 30 (.36) 18 (.31) 12 (.46) 63 (.34)
Total 178 94 62 32 84 58 26 186
Vb8-BamHI:
1 86 (.48) 42 (.45) 31 (.50) 11 (.34) 44 (.51) 29 (.48) 15 (.58) 96 (.50)
2 94 (.52) 52 (.55) 31 (.50) 21 (.66) 42 (.49) 31 (.52) 11 (.42) 96 (.50)
Total 180 94 62 32 86 60 26 192
Vb11-BamHI:
1 91 (.51) 51 (.54) 29 (.47) 22 (.69) 40 (.47) 31 (.52) 9 (.35) 87 (.46)
2 89 (.49) 43 (.46) 33 (.53) 10 (.31) 46 (.53) 29 (.48) 17 (.65) 102 (.54)
Total 180 94 62 32 86 60 26 189
Cb-BglII:
1 88 (.49) 44 (.47) 28 (.45) 16 (.50) 44 (.51) 33 (.55) 11 (.42) 105 (.55)
2 92 (.51) 50 (.53) 34 (.55) 16 (.50) 42 (.49) 27 (.45) 15 (.58) 87 (.45)
Total 180 94 62 32 86 60 26 192
Cb-KpnI:
1 43 (.35) 22 (.35) 13 (.36) 9 (.35) 21 (.35) 11 (.31) 10 (.42) 55 (.43)
2 79 (.65) 40 (.65) 23 (.64) 17 (.65) 39 (.65) 25 (.69) 14 (.58) 72 (.57)
Total 122 62 36 26 60 36 24 127
a Allele designations are as in figure 1.
MS patients were significantly different from those in
DRw15 RP MS patients ( ; ), with a2x  5.75 P  .032
highly significant overrepresentation of the 2-1 subhap-
lotype (67% vs. 35%) ( ; ;2x  5.73 P  .008 RR 1
) (table 3).3.8
We next tested the hypothesis that the gene associated
with progression of MS in DRw15 MS patients maps
nearer to the Vb11-BamHI locus than to the Vb8-
BamHI locus (Beall et al. 1993). Only at the Vb8-BamHI
and Vb11-BamHI loci in the DRw15 RP MS portion
of the data set were the risk-allele frequencies signifi-
cantly different from control-allele frequencies, with
greater differences being seen at the 3′ (Vb11-BamHI)
end (table 5). Only at the Vb11-BamHI locus in the
DRw15 RP MS portion of the data set were disease-
genotype frequencies significantly different fromcontrol-
genotype frequencies ( ; ), confirming2x  5.12 P  .042
our previous observations (Beall et al. 1993), because of
a significantly increased representation (50% vs. 24%)
of the 1,1 genotype ( ; ; ).2x  4.73 P  .02 RR  3.241
These findings were not seen in the DRw15 MS group
(table 1). Only at the Vb11-BamHI locus were disease-
genotype frequencies in DRw15 RP MS patients sig-
nificantly different from those in DRw15 RR MS pa-
tients ( ; ), primarily because of an in-2x  3.06 P  .042
creased representation (50% vs. 26%) of the 1,1
genotype in DRw15 RP MS patients ( ;2x  2.75 P 1
; ). We conclude from these results that.048 RR  2.88
recessive inheritance of a gene linked to the Vb11-
BamHI 1 allele confers an approximately three-times-
increased risk for progression from RR MS to RP MS
if the patient also coinherits the DRw15 allele.
Since this is a family-based association test (Thomson
1995), the results support the hypothesis that suscepti-
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bility to RP MS in DRw15 patients is associated with
recessive inheritance of a gene linked to (or located on)
the 3′ end of the 2-1 subhaplotype delimited by the Vb8-
BamHI and Vb11-BamHI loci. This family-based as-
sociation test confirms our previous hypothesis (Beall et
al. 1989, 1993). The hypothesis is further strengthened
by the lack of differences at other loci 5′ and 3′ to these
test loci.
Susceptibility to RP MS (but Not to RR MS),
in DRw15 Patients
Examination of the subhaplotype frequencies in the
DRw15 portion of the data set showed that differences
were found only in the region delimited by the Vb1-TaqI
and Vb8-MspI loci in RP MS (but not in RR MS) pa-
tients (table 4). The major contributor to the difference
was a highly significant increased representation of the
1-1 and 2-2 subhaplotypes delimited by these two loci
( ; ; ), in RPMS patients com-2x  8.8 P  .003 RR  3.61
pared with control subhaplotypes (table 3). We conclude
from these results that coinheritance of a DRw15 ma-
jor-histocompatibility-complex (MHC) class II allele
with inheritance of the 1-1 and 2-2 subhaplotypes de-
limited by these two loci confers a 3.6-times-increased
risk of progression.
For further exploration of these findings, the subhap-
lotype frequencies were compared between the RR MS
and RP MS patients who were DRw15 (table 3). The
comparison showed highly significant differences
( ; ). These differences were primarily2x  9.85 P  .0072
due to a highly significant increase of the 1-1 subhap-
lotype in the MS patients who were in the progressive
form of their disease, compared with the RRMS patients
( ; ; ). Comparison of allele2x  6.27 P  .01 RR  7.11
frequencies between RR MS and RP MS patients was
performed at each of the loci (Vb1-TaqI and Vb8-MspI),
to determine where on the 1-1 subhaplotype the gene
for progression was located (table 2). Differences were
greatest at the Vb1-TaqI ( ; ;2x  4.75 P  .03 RR 1
) end of the subhaplotype, compared with the Vb8-4.2
MspI ( ; ) end of the subhaplotype. We2x  1.79 P  .181
conclude from these results that inheritance of a gene
located on the 5′ end of the 1-1 subhaplotype delimited
by these two loci confers a 7.1-times-increased risk for
progression after an RR MS course, if there is also coin-
heritance of MHC class II alleles that are not DRw15.
DRw15 Allele as Not Associated with a Gene Linked
to the Progression of MS
It is possible that progression of disease is associated
with a gene linked to DRw15 alone. This hypothesis
was tested by use of the simplex-family data set. The
DRw15 allele was highly significantly associated with a
gene linked with susceptibility to both RR MS ( 2x 1
; ) and RP MS ( ;218.81 P  .000014 x  15.02 P 1
). We conclude from these data that susceptibility.0001
to both RR MS and RP MS is associated with a gene
linked to the DRw15 allele, thus supporting our earlier
data from AFBACs (Beall et al. 1995). The DRw15 allele
is not, however, involved in the progression of MS (in
fact, the aforementioned data support the hypothesis
that it is negatively associated with progression).
Discussion
The results described in this paper confirm and extend
our original findings (Beall et al. 1987a, 1989, 1993;
Charmley et al. 1991) by showing that epistasis between
the HLA class II DRw15 allele and recessive inheritance
of the upper allele (the 1 allele) of the Vb11-BamHI
DNA polymorphism predisposes to RP MS (but not to
RR MS). The results also support the hypothesis that
epistasis between an HLA class II allele that is not
DRw15 and inheritance of a gene located on the 5′ (cen-
tromeric) end of the 1-1 subhaplotype defined by the
Vb1-TaqI and Vb8-MspI DNA polymorphisms also pre-
disposes to RP MS. Before we discuss the implications
of these results, it is important to explore the controversy
that has erupted around this locus and to review reasons
why our previous studies, as well as linkage studies, have
not been entirely reproducible.
Those TcR b-chain association studies that rely on a
case-control experimental paradigm are subject to ex-
perimental bias with regard to ethnic diversity and pop-
ulation stratification, leading to false associations
(Hodge 1993; Lander and Schork 1994; Thomson
1995). These ambiguities are lessened by the use of
AFBACs, as we have done in the present study. There
are, however, even more-subtle forms of bias. First,
RFLPs discovered in the TcR Vb region statistically will
probably be located in either noncoding regions or in-
trons and thus will have no basis for selection. Only if
they are in linkage disequilibrium with an important
coding segment will they be positively selected and thus
be associated with disease. Haplotype analysis (which
presumably “surrounds” at-risk genes by looking at the
region between two loci) may detect regions containing
susceptibility genes that would be missed by the use of
noncoding region–allele analysis. Second, a case-control
study, a priori, is biased in the assignment of haplotypes,
because coupling phase cannot be established; only in-
dividuals who are doubly or singly homozygous at two
adjacent polymorphisms will contribute haplotypes to
the analysis (i.e., double heterozygotes cannot be
scored). Thus, in theory, only one-half of all haplotypes
can be scored. In addition, previous studies that relied
on these criteria that we have proposed for assignment
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Table 3
Subhaplotype Frequencies Determined on the Basis of Vb and Cb Alleles in Caucasian MS Simplex and
Multiplex Families from British Columbia
TcR b
SUBHAPLOTYPEa
NO. (FREQUENCY) OF SUBHAPLOTYPES
DRw15
and
DRw15
At Risk
Control
DRw15 DRw15
All RR MS RP MS All RR MS RP MS
Vb7- BamHI/
Vb1-TaqI:
1-1 3 (.02) 2 (.02) 0 (.00) 2 (.07) 1 (.01) 0 (.00) 1 (.04) 1 (.01)
1-2 87 (.55) 46 (.53) 36 (.64) 10 (.33) 41 (.57) 26 (.54) 15 (.63) 89 (.54)
2-1 9 (.06) 5 (.06) 2 (.04) 3 (.10) 4 (.06) 2 (.04) 2 (.08) 18 (.11)
2-2 42 (.27) 21 (.24) 13 (.23) 8 (.27) 21 (.29) 17 (.35) 4 (.17) 32 (.20)
3-1 9 (.06) 6 (.07) 3 (.05) 3 (.10) 3 (.04) 1 (.02) 2 (.08) 9 (.05)
3-2 8 (.05) 6 (.07) 2 (.04) 4 (.13) 2 (.03) 2 (.04) 0 (.00) 15 (.09)
Total 158 86 56 30 72 48 24 164
Vb1-TaqI/Vb8-
MspI:
1-1 17 (.10) 10 (.11) 4 (.07) 6 (.20) 7 (.09) 2 (.04) 5 (.21) 14 (.08)
1-2 5 (.03) 3 (.03) 1 (.02) 2 (.07) 2 (.03) 1 (.02) 1 (.04) 14 (.08)
2-1 99 (.59) 54 (.61) 36 (.62) 18 (.60) 45 (.56) 37 (.66) 8 (.33) 103 (.60)
2-2 47 (.28) 21 (.24) 17 (.29) 4 (.13) 26 (.33) 16 (.29) 10 (.42) 40 (.23)
Total 168 88 58 30 80 56 24 171
Vb8-MspI/
Vb8-BamHI:
1-1 26 (.16) 14 (.16) 10 (.18) 4 (.13) 12 (.15) 9 (.17) 3 (.13) 33 (.20)
1-2 86 (.52) 48 (.56) 28 (.50) 20 (.67) 38 (.49) 28 (.52) 10 (.42) 79 (.48)
2-1 50 (.30) 23 (.27) 17 (.30) 6 (.20) 27 (.35) 17 (.31) 10 (.42) 53 (.32)
2-2 2 (.01) 1 (.01) 1 (.02) 0 (.00) 1 (.01) 0 (.00) 1 (.04) 1 (.01)
Total 164 86 56 30 78 54 24 166
Vb8-BamHI/
Vb11-
BamHI:
1-1 4 (.02) 3 (.05) 2 (.03) 1 (.03) 1 (.01) 1 (.02) 0 (.00) 4 (.02)
1-2 76 (.45) 36 (.41) 27 (.47) 9 (.30) 40 (.50) 25 (.46) 15 (.58) 88 (.51)
2-1 82 (.49) 46 (.52) 26 (.45) 20 (.67) 36 (.45) 27 (.50) 9 (.35) 73 (.42)
2-2 6 (.04) 3 (.03) 3 (.05) 0 (.00) 3 (.04) 1 (.02) 2 (.08) 8 (.05)
Total 168 88 58 30 80 54 26 173
Vb11-BamHI/
Cb-BglII:
1-1 49 (.30) 30 (.33) 18 (.30) 12 (.40) 19 (.25) 15 (.30) 4 (.15) 48 (.28)
1-2 34 (.20) 19 (.21) 10 (.17) 9 (.30) 15 (.20) 10 (.20) 5 (.19) 29 (.17)
2-1 31 (.19) 12 (.13) 9 (.15) 3 (.10) 22 (.29) 12 (.24) 7 (.27) 47 (.27)
2-2 52 (.31) 29 (.32) 23 (.38) 6 (.20) 20 (.26) 13 (.26) 10 (.38) 49 (.28)
Total 166 90 60 30 76 50 26 173
Cb-BglII/Cb-
KpnI:
1-1 27 (.25) 15 (.27) 10 (.29) 5 (.23) 12 (.23) 6 (.19) 6 (.30) 38 (.35)
1-2 25 (.25) 12 (.21) 5 (.15) 7 (.32) 13 (.25) 11 (.34) 2 (.10) 20 (.18)
2-1 8 (.07) 4 (.07) 2 (.06) 2 (.09) 4 (.08) 2 (.06) 2 (.10) 11 (.10)
2-2 48 (.44) 25 (.45) 17 (.50) 8 (.36) 23 (.44) 13 (.41) 10 (.50) 40 (.37)
Total 108 56 34 22 52 32 20 109
a Allele designations are as in figure 1.
of haplotypes (Beall et al. 1987a, 1989, 1993) could have
missed instances of recombination between adjacent
loci. In this study, we in fact found instances of single
and double recombination flanking the at-risk regions
(data not shown). Recombination between adjacent loci
(which will not be detected in case-control studies) in-
validates the assignment of subhaplotypes by means of
our previous (Beall et al. 1987a, 1989, 1993) experi-
mental design. This problem will be most pronounced
in adjacent alleles that are in the greatest amount of
linkage equilibrium. Third, studies that have used “con-
trol” populations containing high allele frequencies of
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Table 4
Comparison of Subhaplotype Frequencies Determined on the Basis of Vb and Cb Alleles in
Caucasian MS Simplex and Multiplex Families from British Columbia
TcR b HAPLOTYPE
DRw15 DRw15
DRw15
AND
DRw15:
AllAll RP MS RR MS All RP MS RR MS
Vb8-BamHI/Vb11-BamHI:
2x2 2.52 6.19 .40 .43 .54 1.44 1.51
P .14 .02 .82 .81 .76 .49 .47
Vb11-BamHI/Cb-BglII:
2x3 6.59 7.41 4.27 .55 2.19 .53 3.64
P .09 .06 .23 .91 .41 .91 .30
Vb8-MspI/Vb8-BamHI:
2x2 1.53 3.70 .10 .53 .91 .46 .95
P .47 .16 .95 .77 .63 .80 .62
Cb-BglII/Cb-KpnI:
2x3 1.88 2.45 2.08 3.06 1.56 5.45 3.61
P .60 .48 .56 .38 .67 .14 .31
Vb1-TaqI/Vb8-MspI:
2x3 2.67 4.83 3.49 4.65 9.31 4.58 5.17
P .45 .18 .32 .20 .03 .21 .16
Vb7-BamHI/Vb1-TaqI:
2x4 3.40 6.95 5.25 6.56 3.92 8.19 6.58
P .25 .14 .26 .16 .42 .08 .16
NOTE.—Significant P values are underlined.
Table 5
Comparison of Allele Frequencies Determined on the Basis of Vb and Cb Alleles in Caucasian MS
Simplex and Multiplex Families from British Columbia
DRw15 DRw15
DRw15 AND DRw15: AllAll RP MS RR MS All RP MS RR MS
Vb11:
2x1 1.70 5.65 .01 .005 1.20 .58 .76
P .10 .009a .92 .94 .27 .45 .19
Vb8-BamHI:
2x1 .72 2.68 .00 .03 .54 .05 .18
P .20 .05b 1.00 .86 .46 .82 .67
Vb8-MspI:
2x1 .76 1.80 .05 .09 1.50 .16 .14
P .38 .18 .82 .76 .22 .69 .71
Vb1-TaqI:
2x1 .22 2.20 3.02 1.37 1.37 3.99 1.02
P .64 .14 .08 .24 .45 .05c .31
Vb7-BamHI:
2x2 .67 1.04 1.11 .98 2.49 .80 .95
P .72 .60 .57 .61 .14 .67 .62
Cb-BglII:
2x1 1.57 .24 1.71 .30 1.41 .002 1.25
P .21 .62 .19 .58 .24 .96 .26
Cb-KpnI:
2x1 1.06 .67 .60 1.17 .02 1.89 1.69
P .30 .41 .44 .28 .89 .17 .19
NOTE.—Significant P and RR MS values are underlined.
a Relative Risk (RR)  2.58.
b RR  1.91.
c RR  2.89.
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the disease-susceptibility genes tested for may not detect
a positive association (Kellar-Wood et al. 1995). Last,
case-control methods that have used Southern analysis
to study these questions may have been biased because
of migration artifacts or partial digestions, and studies
that have used PCR-based methods may have been bi-
ased because of genotyping ambiguity due to the infi-
delity of Taq polymerase. The use of family-based data
(wherein segregation of alleles in Mendelian fashion
must occur), as has been utilized in the present study,
lessens this last experimental bias and more effectively
circumvents all of the aforementioned problems of ex-
perimental design.
An important finding of this study is that, although
there was a nonsignificant trend of susceptibility to MS
being associated with a gene linked to the Vb11-BamHI
DNA polymorphism ( ; ; table 5), the2x  .76 P  .191
effect was more marked ( ; ; table 5) in2x  1.70 P  .101
the HLA class II DRw15 MS patients, supporting our
original conclusions (Beall et al. 1987a, 1989, 1993) and
others (Kellar-Wood et al. 1995; Wood et al. 1995; Epp-
len et al. 1997), again demonstrating epistasis between
the HLA class II region and the TcR b-chain locus, in
conferring susceptibility to MS. There was virtually no
effect of this region in HLA class II DRw15MSpatients
(table 5). It is important to note that, with regard to the
Vb11-BamHI DNA polymorphism, there was a highly
significant effect in the RP MS subset ( ;2x  5.65 P 1
; ), whereas there was no effect in the.009 RR  2.58
RRMS subset ( ; ) (table 5). Our findings2x  .01 P  .921
support recent findings by Wei et al. (1995), who, in
their population of primarily RR MS patients, have also
failed to see in this region an effect. This gene is located
at the 3′ end of the 2-1 subhaplotype defined by the Vb8-
BamHI and Vb11-BamHI alleles and is recessively
inherited.
We have also shown that, in HLA class II DRw15
MS patients, susceptibility to the progressive form of the
disease is associated with a gene linked to the Vb1-TaqI
DNA polymorphism, which is located on the 1-1 sub-
haplotype defined by the Vb1-TaqI and Vb8-MspI al-
leles. These findings are similar to those recently reported
by Epplen et al. (1997). It will be important to define
first of all which allele (other than DRB1*1501) is a
secondary risk allele, by use of the method of relative
predispositional effects (Payami et al. 1989). Next, it
will be of interest to look at these initial results in an
expanded data set selected for that secondary risk allele.
This study also supports recent findings with the two
most completely studied animal models of MS, EAE-
and TMEV-induced demyelination (Dal Canto et al.
1995). Goverman et al. (1993) constructed transgenic
mice that expressed genes encoding a rearranged T cell
receptor specific for myelin basic protein and that de-
veloped EAE spontaneously in a nonsterile environment
(but not in a sterile environment). Similarly, Rodriguez
et al. (1992, 1994) showed that strains of mice with
massive deletions of the TcR b-chain complex develop
severe demyelination if they also inherit the appropriate
H-2 complex.
The results of the present study may explain the dis-
parate results that were found in the recent worldwide
genome search for susceptibility genes in MS (Ebers et
al. 1996; Haines et al. 1996; Sawcer et al. 1996). Our
original experimental design (Beall et al. 1987a, 1989)
studied severely affected (CP andRP)MS patients, which
may have expedited the discovery of genes that are in-
volved in progression (Beall et al. 1993; present study)
but that may not have been found had the whole pop-
ulation of MS patients been analyzed. Recent work sup-
ports this hypothesis. Mahtani et al. (1996) have recently
completed, in Finnish families, a genome scan for sus-
ceptibility to type 2 diabetes. By selecting patients who
were phenotypically more severely affected, they uncov-
ered genes originally missed in the population as a
whole. The disparate results reported recently by three
groups (reviewed in Bell and Lathrop 1996) regarding
genetic susceptibility to MS may be due to phenotypic
differences. Tertiary-care referral centers utilized by the
U.S. medical-care systemmay follow patients withmore-
severe forms of MS and thus may uncover different
genes, compared with centers that follow patients with
a wide spectrum of disease. Supporting this hypothesis
is the fact that the U.S. group (Haines et al. 1996) tar-
geted the TcR b-chain complex (or a gene closely linked
to it) as a possible candidate gene other than HLA.
It is understood that a certain percentage of RR MS
patients will enter a progressive phase after an unknown
period. Only by periodically updating our data set will
we be able to detect differences in genotype-phenotype
correlation. In this population, which is free from as-
certainment bias, we estimate that in 10% of our pa-
tients the disease will be benign (Weinshenker et al.
1989). Conversely, certain of our RR MS patients will
undergo a severe secondary progressive course. It will
be extremely important to define these populationsmore
precisely at the genetic level, to look at how genetic
susceptibility influences the course of disease over time.
Our system of the semirelational database COSTAR and
the heuristic CHIAARRA (Beall et al. 1996; S. S. Beall,
M.K. Hockertz, D. Studney, and D.W. Paty, unpublished
data)—a system that, by use of input phenotypic para-
meters from COSTAR, automatically updates experi-
mental analysis of genetic data—will facilitate this
process.
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